• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Material Twisted/Bent (2981)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/21/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.The actual device has been returned for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.A review of the device history record of the product code/lot# combination was conducted with no findings.
 
Event or Problem Description
The user facility reported that the angio-seal introducer bent when attempting to put over the wire, causing them to discard and grab a new angio-seal.The patient was in stable condition.The procedure outcome was a success.There was no patient injury, medical/surgical intervention required.There were no other devices or equipment used with the reported product.Additional information was received on 05march2021: the type of procedure that was being performed was a peripheral angiogram using a french sheath.A pre-deployment angiogram was performed.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to update section h3, and to provide the completed investigation results.H6: investigation findings - 3221 is based upon evaluation of the returned sample; 213 is based upon dimension testing of the returned sample.One used 6fr angio-seal evolution was received for product evaluation.The hemostasis sheath was returned mated with the arteriotomy locator.Unopened carrier tube assembly and guide wire was returned as well.Upon visual analysis, the arteriotomy locator was found to be appropriately locked with the hemostasis sheath and blood-like substances were found on the arteriotomy locator and hemostasis sheath.A slight bend was noted on hemostasis sheath.The locator/sheath assembly was examined under the microscope a kink was observed near the blood inlet holes.No anomalies were noted at the transition between arteriotomy locator and hemostasis sheath.No other visual anomalies were noted with the returned components.For dimension testing, the outer diameter of the arteriotomy locator was measured and found to be 0.090'' and which was within the specification of 0.092" +0.00/-0.02.The outer diameter of the sheath was measured to be 0.115'' which was within the specification of 0.114" +/-0.005".All measurements were within the specifications defined in the engineering drawings active at the time of manufacturing.Based on the returned device, the complaint could be confirmed for a bent in the locator, which likely happened while the user was attempting to insert the assembly into arteriotomy.The application of off-axis forces during insertion or presence of scar tissue could have been the cause of the bends or kinks.The arteriotomy locator and sheath were dimensionally and no anomalies were noted.Based on the available information, the exact cause of the issue cannot be determined.The device was in a conforming state when released from terumo control.There is no indication that any manufacturing, design, or quality system issues may have led to this event.Currently, no action is recommended since this risk evaluation is within the predetermined limits in the failure mode and effects analysis (fmea).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US
Common Device Name
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
265 davidson ave
suite 320
somerset NJ 08873
MDR Report Key11506228
Report Number3013394970-2021-00128
Device Sequence Number4088427
Product Code MGB
UDI-Device Identifier00389701011783
UDI-Public00389701011783
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P930038
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,user f
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 03/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/13/2020
Device Model NumberN/A
Device Catalogue NumberC610134
Device Lot Number06101907
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/11/2021
Initial Date Received by Manufacturer 02/22/2021
Supplement Date Received by Manufacturer04/14/2021
Initial Report FDA Received Date03/17/2021
Supplement Report FDA Received Date04/19/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-